CROHN DISEASE (CD)
Clinical trials for CROHN DISEASE (CD) explained in plain language.
Never miss a new study
Get alerted when new CROHN DISEASE (CD) trials appear
Sign up with your email to follow new studies for CROHN DISEASE (CD), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could one drug be enough? new study challenges combo therapy for IBD
Disease control ENROLLING_BY_INVITATIONThis study compares two treatments for Crohn's disease and ulcerative colitis: using the drug infliximab alone versus combining it with another immune-suppressing drug. The goal is to see if the single drug can keep patients in remission without steroids just as well as the combo…
Matched conditions: CROHN DISEASE (CD)
Sponsor: University Hospital, Clermont-Ferrand • Aim: Disease control
Last updated May 17, 2026 02:08 UTC
-
New study probes daily life challenges for IBD patients
Knowledge-focused ENROLLING_BY_INVITATIONThis study aims to understand how inflammatory bowel disease (IBD) affects patients' quality of life and what factors play a role. Researchers will survey 385 adults with Crohn's disease or ulcerative colitis about their symptoms, emotional well-being, social support, and daily f…
Matched conditions: CROHN DISEASE (CD)
Sponsor: Cairo University • Aim: Knowledge-focused
Last updated May 17, 2026 02:07 UTC
-
2000-Patient study aims to predict which IBD treatments work best
Knowledge-focused ENROLLING_BY_INVITATIONThis study is collecting health information from 2000 people with Crohn's disease or ulcerative colitis to create tools that predict how well different treatments will work. The goal is to help doctors choose the right biologic or small-molecule drug for each patient. Participant…
Matched conditions: CROHN DISEASE (CD)
Sponsor: Seoul National University Hospital • Aim: Knowledge-focused
Last updated May 17, 2026 02:02 UTC
-
Ultrasound could replace colonoscopies for Crohn's patients on new drug
Knowledge-focused OngoingThis study looks at how fast risankizumab (Skyrizi) heals all layers of the gut in people with Crohn's disease. Instead of repeated colonoscopies, researchers use intestinal ultrasound to check healing at 4 and 12 weeks. About 109 adults starting risankizumab in routine care will…
Matched conditions: CROHN DISEASE (CD)
Sponsor: University Hospital, Clermont-Ferrand • Aim: Knowledge-focused
Last updated May 14, 2026 12:06 UTC